Cologne, Germany

Heino Stab

This inventor holds 2 USPTO granted patents. Top assignee: Bayer Schering Pharma Ag. Active years: 2010-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heino Stab. Retrieved from https://idiyas.com/inventor/heino-stab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2010-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Heino Stab: Innovator in Quinolone Antibiotics

Introduction

Heino Stab is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of quinolone antibiotics. With a total of 2 patents, his work has had a meaningful impact on medical treatments.

Latest Patents

Stab's latest patents focus on sustained-release preparations of quinolone antibiotics. The first patent describes an orally administrable preparation that releases the active compound with a delay. The second patent outlines a method for preparing these sustained-release formulations, ensuring that the quinolone antibiotic is delivered effectively over time.

Career Highlights

Heino Stab is associated with Bayer Schering Pharma AG, a leading company in the pharmaceutical industry. His work at Bayer has allowed him to explore innovative solutions in antibiotic delivery systems. His expertise in this area has positioned him as a valuable asset to the company.

Collaborations

Stab has collaborated with notable colleagues, including Venkata-Rangarao Kanikanti and Roland Rupp. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical technologies.

Conclusion

Heino Stab's contributions to the field of quinolone antibiotics exemplify the importance of innovation in healthcare. His patents and work at Bayer Schering Pharma AG highlight his commitment to improving medical treatments through advanced pharmaceutical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…